ArticleBlood2013

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program.

Shimin Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.